MODERNA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 108 USD | +1.69% |
|
+3.36% | +8.57% |
| Apr. 24 | Sector Update: Health Care Stocks Slipping Late Afternoon | MT |
| Apr. 24 | Moderna to Collaborate With OpenAI to Launch New Generation of Medicines | MT |
ETFs positioned on Moderna, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 5.66% | 0 M€ | 0.00% | - | |
| 4.69% | 2 M€ | -.--% | ||
| 4.08% | 0 M€ | 0.00% | - | |
| 2.50% | 1 M€ | 0.00% | - | |
| 2.40% | 18 M€ | +3.79% | - | |
| 2.08% | 7 M€ | -.--% | - | |
| 1.81% | 8 M€ | +2.44% | ||
| 1.36% | 9 M€ | -4.31% | - | |
| 1.21% | 1 M€ | +2.21% | - | |
| 0.90% | 1,182 M€ | +1.06% | ||
| 0.81% | 1 M€ | 0.00% | - | |
| 0.72% | 2 M€ | +6.77% | ||
| 0.63% | 3 M€ | 0.00% | - | |
| 0.60% | 9 M€ | -.--% | - | |
| 0.55% | 5 M€ | -72.95% | - | |
| 0.45% | 22 M€ | 0.00% | - | |
| 0.34% | 40 M€ | -.--% | ||
| 0.30% | 24 M€ | +12.01% | ||
| 0.22% | 374 M€ | +15.20% | - | |
| 0.21% | 8 M€ | +3.41% | - | |
| 0.21% | 33 M€ | +0.25% | - | |
| 0.21% | 18 M€ | +3.41% | - |
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows:
- revenue from product sales (95.7%) ;
- revenues from grants (4%);
- revenues from collaboration agreements (0.3%).
At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development.
Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Calendar
2024-05-02
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
106.2
USD
Average target price
134.3
USD
Spread / Average Target
+26.48%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +8.57% | 40.65B | |
| +1.51% | 42.59B | |
| +49.22% | 40.57B | |
| -12.36% | 26.77B | |
| +8.92% | 24.81B | |
| -25.13% | 18.17B | |
| +29.17% | 12.05B | |
| -3.12% | 11.7B | |
| +6.35% | 11.1B | |
| -16.98% | 9.85B |
- Stock Market
- Equities
- MRNA Stock
- Funds and ETFs Moderna, Inc.
